Pfizer seeks Collaboration in the fight against Illicit Trade as PSN’s President Visits

The President of Pharmaceutical Society of Nigeria Prof. Cyril Usifoh recently paid a courtesy visit to Pfizer’s office in Nigeria. He was received by the Country Manager/Cluster Lead for West Africa, Pharmacist Olayinka Subair who reiterated the need for industry players to join forces in creating awareness around the dangers of counterfeit medicine and pharmaceutical products.
Olayinka Subair commented that the threat of counterfeits is not going away. That Pfizer is seeking collaboration with stakeholders on efforts to educate consumers about counterfeit medicines because patients need the knowledge to protect their health from counterfeiters.

Counterfeit medicines often miss key ingredients and dosages, or contain added, harmful ingredients. As a result, patients who take counterfeits, including life-saving medicines for cancer and heart disease, lose the therapeutic benefits they rely on to treat their conditions.

To tackle the threat of counterfeits to patient health, Pfizer is collaborating with industry stakeholders to ensure patients have the information they need to avoid counterfeit medicines. Pfizer is seeking collaboration with government agencies, pharmaceutical organizations, doctors, pharmacists, and industry partners to help raise awareness of the growing problem of counterfeit medicines.

“Together, we seek to tackle this threat to patient health by stopping counterfeits before they reach patients, giving consumers information they need to make the right choices, and supporting health care providers in our communities.” said Subair.

Prof. Cyril Usifoh, Pharmaceutical Society of Nigeria’s President responded that “The Pharmaceutical Society of Nigeria as a body that seeks to maintain a high standard of Professional ethics and discipline among its members would give all the support to work together with Pfizer. We would see how we can amplify by reaching out to stakeholders and see how far we can go in driving this campaign successfully.”

Pfizer is reputed for applying science and global resources to bring therapies that extend and significantly improve the lives of people as they strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. They strive to advance wellness, prevention, treatments, and cures that challenge the most feared diseases as one of the world’s premier innovative biopharmaceutical companies collaborates with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. In its more than 150 years, Pfizer has worked to make a difference for all who rely on them.